Properties of purified CYP2R1 in a reconstituted membrane environment and its 25-hydroxylation of 20-hydroxyvitamin D3

J Steroid Biochem Mol Biol. 2018 Mar:177:59-69. doi: 10.1016/j.jsbmb.2017.07.011. Epub 2017 Jul 14.

Abstract

Recent studies indicate that CYP2R1 is the major 25-hydroxylase catalyzing the first step in vitamin D activation. Since the catalytic properties of CYP2R1 have been poorly studied to date and it is a membrane protein, we examined the purified enzyme in a membrane environment. CYP2R1 was expressed in E. coli and purified by nickel affinity- and hydrophobic interaction-chromatography and assayed in a reconstituted membrane system comprising phospholipid vesicles plus purified human NADPH-P450 oxidoreductase. CYP2R1 converted vitamin D3 in the vesicle membrane to 25-hydroxyvitamin D3 [25(OH)D3] with good adherence to Michaelis-Menten kinetics. The kinetic parameters for 25-hydroxylation of vitamin D3 by the two major vitamin D 25-hydroxylases, CYP2R1 and CYP27A1, were examined in vesicles under identical conditions. CYP2R1 displayed a slightly lower kcat than CYP27A1 but a much lower Km for vitamin D3, and thus an overall 17-fold higher catalytic efficiency (kcat/Km), consistent with CYP2R1 being the major vitamin D 25-hydroxylase. 20-Hydroxyvitamin D3 [20(OH)D3], the main product of vitamin D3 activation by an alternative pathway catalyzed by CYP11A1, was metabolized by CYP2R1 to 20,25-dihydroxyvitamin D3 [20,25(OH)2D3], with catalytic efficiency similar to that for the 25-hydroxylation of vitamin D3. 20,25(OH)2D3 retained full, or somewhat enhanced activity compared to the parent 20(OH)D3 for the inhibition of the proliferation of melanocytes and dermal fibroblasts, with a potency comparable to 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]. The 20,25(OH)2D3 was also able to act as an inverse agonist on retinoic acid-related orphan receptor α, like its parent 20(OH)D3. Thus, the major findings of this study are that CYP2R1 can metabolize substrates in a membrane environment, the enzyme displays higher catalytic efficiency than CYP27A1 for the 25-hydroxylation of vitamin D, it efficiently hydroxylates 20(OH)D3 at C25 and this product retains the biological activity of the parent compound.

Keywords: 25-hydroxylase; CYP2R1; Phospholipid vesicles; Vitamin D3.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcifediol / analogs & derivatives*
  • Calcifediol / pharmacology
  • Cell Membrane / metabolism
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Cholestanetriol 26-Monooxygenase / genetics
  • Cholestanetriol 26-Monooxygenase / metabolism*
  • Cytochrome P-450 Enzyme System / metabolism
  • Cytochrome P450 Family 2 / genetics
  • Cytochrome P450 Family 2 / metabolism*
  • Escherichia coli / genetics
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Humans
  • Hydroxylation
  • Melanocytes / drug effects
  • Melanocytes / metabolism
  • Nuclear Receptor Subfamily 1, Group F, Member 1 / metabolism
  • Vitamins / pharmacology*

Substances

  • 20-hydroxyvitamin D3
  • Nuclear Receptor Subfamily 1, Group F, Member 1
  • POR protein, human
  • RORA protein, human
  • Vitamins
  • Cytochrome P-450 Enzyme System
  • Cytochrome P450 Family 2
  • CYP2R1 protein, human
  • CYP27A1 protein, human
  • Cholestanetriol 26-Monooxygenase
  • Calcifediol